Breaking the Seal on Drug Research - The New York Times
Peter Doshi, editor asociado de The BMJ: “Los ensayos de la vacuna no pueden decirnos si salvará vidas”
Re: Tamiflu email exchanges with the Centers for Disease Control and Prevention (CDC): BETA site | The BMJ
Re: Tamiflu correspondence with Roche | The BMJ
Es BMJ un "news blog"? Facebook contra la ciencia y democracia - Diario de futuro - Blogs de Opinión de LaVanguardia.comDiario de futuro
EMA recommendation on hydroxyethyl starch solutions obscured controversy
![PDF] Crowdfunding investigative journalism at <i>The BMJ</i> by Rebecca Coombes, Peter Doshi · 10.1136/bmj.o803 · OA.mg](https://og.oa.mg/Crowdfunding%20investigative%20journalism%20at%20%3Ci%3EThe%20BMJ%3C%2Fi%3E.png?author=%20Rebecca%20Coombes,%20Peter%20Doshi "PDF] Crowdfunding investigative journalism at <i>The BMJ</i> by Rebecca Coombes, Peter Doshi · 10.1136/bmj.o803 · OA.mg")
PDF] Crowdfunding investigative journalism at <i>The BMJ</i> by Rebecca Coombes, Peter Doshi · 10.1136/bmj.o803 · OA.mg
Parecido a Gotzsche, Peter Doshi ha llevado a los tribunales al gobierno de Canadá porque no le permitían acceder a los datos de la vacuna del VPH para revisarlos. Ganó el juicio.
GIJN Webinar — Investigating the Pandemic: Behind the COVID-19 Vaccine Race - Global Investigative Journalism Network
Global Investigative Journalism Network on Twitter: "If you're a journalist reporting on #COVID19 vaccines, you'll want to hear from Peter Doshi, @umsop's assoc. prof. of pharmaceutical health services research & @bmj_latest's assoc.
How should we plan for pandemics? Author(s): Peter Doshi Source: BMJ: British Medical Journal, Vol. 339, No. 7721 (12 September
Peter Doshi: Las vacunas "95% eficaces" de Pfizer y Moderna — hay que ser cautelosos y ver primero
Influenza: marketing vaccine by marketing disease
How to Expand Access to COVID Vaccines without Compromising the Science - Scientific American
Re: Tamiflu correspondence with Roche | The BMJ
Will covid-19 vaccines save lives? Current trials aren't designed to tell us | The BMJ
Covid: inmunidad preexistente en hasta el 50%
Biologi per la Scienza - QUANTO È EFFICACE IL VACCINO? La notizia di questi giorni è che secondo Peter Doshi, editore associato del British Medical Journal su cui ha scritto un articolo
The Problem with Current Vaccine Trials: What Journalists Need to be Asking Drug Companies - Global Investigative Journalism Network
Is this trial misreported? Truth seeking in the burgeoning age of trial transparency
chelvi mails (@ChelviMails) / Twitter
PDF) Comment on the BMJ opinion of the associate editor Peter Doshi about “Pfizer and Moderna's 95% effective vaccines—we need more details and the raw data”
Restoring invisible and abandoned trials: a call for people to publish the findings
Unmasking 'Invisible' Drug Trials | Science | AAAS
